Medical
| Tue 21 Apr 2026
Alexandria, April 21 -- AbbVie has applied United States patent for LPAR1 Inhibitors. Korman Henry, Krueger Allan C, Breinlinger Eric, Wilson Noel S, Owens Kyle R, Heyman Howard R, Newton James N, Shrestha Anurupa, Chavez Martin Garcia, Zhao Gang, Liu Bo, Hamza Daniel, Ackrill Thomas D, Mclellan Jayde A and Leeder Alexander J de..